Vector Inc. (TSE:6058) agreed to acquire additional 25.071429% stake in Vitabrid Japan Inc. from Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410) for KRW 13.7 billion on August 25, 2022. For the period ended February 28, 2022, Vitabrid Japan reported Total assets of KRW 30 billion, and sales of KRW 106 billion. The acquisition is expected to be closed on August 29, 2022.

Vector Inc. (TSE:6058) completed the acquisition of additional 25.071429% stake in Vitabrid Japan Inc. from Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410) for KRW 13.7 billion on August 31, 2023.